Last updated on August 2017

Pancreatic Enzyme Supplementation for Celiac Disease


Brief description of study

The purpose of this protocol is to conduct a pilot study to investigate whether pancreatic enzyme supplementation will improve symptoms in individuals with celiac disease who suffer persistent symptoms despite a gluten free diet. This protocol specifically aims to: 1. Evaluate the efficacy of pancreatic enzyme supplementation for reduction of gastrointestinal symptoms in patients with celiac disease on a gluten free diet. 2. Assess the ability of fecal elastase levels to predict response to pancreatic enzyme supplementation in patients with celiac disease on a gluten free diet.

Clinical Study Identifier: NCT02475369

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Sarah Madoff, BS

Beth Israel Deaconess Medical Center
Boston, MA United States
  Connect »